These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 15618008)

  • 21. The cytoplasmic 'linker region' in Toll-like receptor 3 controls receptor localization and signaling.
    Funami K; Matsumoto M; Oshiumi H; Akazawa T; Yamamoto A; Seya T
    Int Immunol; 2004 Aug; 16(8):1143-54. PubMed ID: 15226270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of lipid A-mediated type I interferon induction by bactericidal/permeability-increasing protein (BPI).
    Azuma M; Matsuo A; Fujimoto Y; Fukase K; Hazeki K; Hazeki O; Matsumoto M; Seya T
    Biochem Biophys Res Commun; 2007 Mar; 354(2):574-8. PubMed ID: 17239348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcriptional activation induced in macrophages by Toll-like receptor (TLR) ligands: from expression profiling to a model of TLR signaling.
    Schmitz F; Mages J; Heit A; Lang R; Wagner H
    Eur J Immunol; 2004 Oct; 34(10):2863-73. PubMed ID: 15368303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mal and MyD88: adapter proteins involved in signal transduction by Toll-like receptors.
    O'Neill LA; Dunne A; Edjeback M; Gray P; Jefferies C; Wietek C
    J Endotoxin Res; 2003; 9(1):55-9. PubMed ID: 12691620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitumor NK activation induced by the Toll-like receptor 3-TICAM-1 (TRIF) pathway in myeloid dendritic cells.
    Akazawa T; Ebihara T; Okuno M; Okuda Y; Shingai M; Tsujimura K; Takahashi T; Ikawa M; Okabe M; Inoue N; Okamoto-Tanaka M; Ishizaki H; Miyoshi J; Matsumoto M; Seya T
    Proc Natl Acad Sci U S A; 2007 Jan; 104(1):252-7. PubMed ID: 17190817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of lipopolysaccharide-inducible genes by MyD88 and Toll/IL-1 domain containing adaptor inducing IFN-beta.
    Hirotani T; Yamamoto M; Kumagai Y; Uematsu S; Kawase I; Takeuchi O; Akira S
    Biochem Biophys Res Commun; 2005 Mar; 328(2):383-92. PubMed ID: 15694359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Toll-like receptors that sense viral infection].
    Seya T; Shingai M; Matsumoto M
    Uirusu; 2004 Jun; 54(1):1-8. PubMed ID: 15449898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Soluble G protein of respiratory syncytial virus inhibits Toll-like receptor 3/4-mediated IFN-beta induction.
    Shingai M; Azuma M; Ebihara T; Sasai M; Funami K; Ayata M; Ogura H; Tsutsumi H; Matsumoto M; Seya T
    Int Immunol; 2008 Sep; 20(9):1169-80. PubMed ID: 18611945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A unique feature of Toll/IL-1 receptor domain-containing adaptor protein is partially responsible for lipopolysaccharide insensitivity in zebrafish with a highly conserved function of MyD88.
    Liu Y; Li M; Fan S; Lin Y; Lin B; Luo F; Zhang C; Chen S; Li Y; Xu A
    J Immunol; 2010 Sep; 185(6):3391-400. PubMed ID: 20702732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LPS, dsRNA and the interferon bridge to adaptive immune responses: Trif, Tram, and other TIR adaptor proteins.
    Hoebe K; Beutler B
    J Endotoxin Res; 2004; 10(2):130-6. PubMed ID: 15120005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling.
    Yamamoto M; Sato S; Mori K; Hoshino K; Takeuchi O; Takeda K; Akira S
    J Immunol; 2002 Dec; 169(12):6668-72. PubMed ID: 12471095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutting Edge: NF-kappaB-activating kinase-associated protein 1 participates in TLR3/Toll-IL-1 homology domain-containing adapter molecule-1-mediated IFN regulatory factor 3 activation.
    Sasai M; Oshiumi H; Matsumoto M; Inoue N; Fujita F; Nakanishi M; Seya T
    J Immunol; 2005 Jan; 174(1):27-30. PubMed ID: 15611223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a Regulatory Acidic Motif as the Determinant of Membrane Localization of TICAM-2.
    Funami K; Matsumoto M; Enokizono Y; Ishii N; Tatematsu M; Oshiumi H; Inagaki F; Seya T
    J Immunol; 2015 Nov; 195(9):4456-65. PubMed ID: 26408662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IRF-7 is the master regulator of type-I interferon-dependent immune responses.
    Honda K; Yanai H; Negishi H; Asagiri M; Sato M; Mizutani T; Shimada N; Ohba Y; Takaoka A; Yoshida N; Taniguchi T
    Nature; 2005 Apr; 434(7034):772-7. PubMed ID: 15800576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toll-like receptor 4 and Toll-IL-1 receptor domain-containing adapter protein (TIRAP)/myeloid differentiation protein 88 adapter-like (Mal) contribute to maximal IL-6 expression in macrophages.
    Schilling D; Thomas K; Nixdorff K; Vogel SN; Fenton MJ
    J Immunol; 2002 Nov; 169(10):5874-80. PubMed ID: 12421970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Viral inhibitory peptide of TLR4, a peptide derived from vaccinia protein A46, specifically inhibits TLR4 by directly targeting MyD88 adaptor-like and TRIF-related adaptor molecule.
    Lysakova-Devine T; Keogh B; Harrington B; Nagpal K; Halle A; Golenbock DT; Monie T; Bowie AG
    J Immunol; 2010 Oct; 185(7):4261-71. PubMed ID: 20802145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I.
    Miyazaki M; Kanto T; Inoue M; Itose I; Miyatake H; Sakakibara M; Yakushijin T; Kakita N; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
    J Med Virol; 2008 Jun; 80(6):980-8. PubMed ID: 18428149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways.
    Hoebe K; Janssen EM; Kim SO; Alexopoulou L; Flavell RA; Han J; Beutler B
    Nat Immunol; 2003 Dec; 4(12):1223-9. PubMed ID: 14625548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergism of Toll-like receptor-induced interleukin-12p70 secretion by monocyte-derived dendritic cells is mediated through p38 MAPK and lowers the threshold of T-helper cell type 1 responses.
    Bohnenkamp HR; Papazisis KT; Burchell JM; Taylor-Papadimitriou J
    Cell Immunol; 2007 Jun; 247(2):72-84. PubMed ID: 17927969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of homodimerization of Toll-like receptor 4 by curcumin.
    Youn HS; Saitoh SI; Miyake K; Hwang DH
    Biochem Pharmacol; 2006 Jun; 72(1):62-9. PubMed ID: 16678799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.